Store
NASH Drug Pipeline and Market Overview
Publication Date: January 6, 2020
Tags: Biopharma, Life Science, Pharma & Biopharma, Pharmaceuticals
Pages: 18
SKU: 20-053
Non-alcoholic steatohepatitis (NASH) is a serious liver disease characterized by inflammation and liver cell damage, which can lead to cirrhosis. Despite the absence of approved medications specifically for NASH, there are nearly 80 drug candidates in development. Kalorama Information’s report, NASH Drug Pipeline and Market Overview, provides an in-depth analysis of these drug candidates, including details on developers, drug types, phase studies, and market entry estimates.
Key Features of the Report:
This comprehensive market analysis offers critical data and business planning resources for stakeholders in the NASH treatment market. The report includes:
- Estimated Treatment Costs: Analysis of low-, mid-, and high-range costs for a 30-day supply of NASH therapies.
- NASH Market Estimates by Region: Projections for the United States & Canada, EMEA, Latin America, and Asia Pacific for 2025.
Market Insights:
- NASH Disease Incidence and Prevalence: Detailed statistics and trends.
- NAFLD Incidence and Prevalence: Insights into the broader context of liver diseases.
- Risk Factor Evaluation: Analysis of contributing factors to NASH.
- Pricing Trends: Overview of current and future pricing dynamics.
- Liver Transplant Statistics and Trends: Key data on transplant needs and trends.
- Expected Market Penetration: Projections for the adoption of emerging therapies.
- Global Treatment Options and Emerging Therapies: Review of current and future treatment landscapes.
For further details and to purchase directly, please contact us.
Description
Non-alcoholic steatohepatitis (NASH) is a type of non-alcoholic fatty liver disease (NAFLD). NASH is characterized by inflammation in the liver and liver cell damage, which can lead to scarring of the liver (cirrhosis). No medications have been approved specifically for NASH but there are numerous products in development. NASH Drug Pipeline and Market Overview looks at the almost 80 drug candidates for the treatment of this disease in terms of developer, type of drug, phase study, and market entrance estimate. In addition, the report provides the following data:
- Estimated Treatment Cost for NASH Therapies, Low-, Mid-, High-Range, 30-day Supply
- NASH Market Estimates by Global Region, 2025 Forecast (United States & Canada, EMEA, Latin America, Asia Pacific)
In creating its market forecast, Kalorama discusses the indicators that needed to be evaluated to create this estimate, commenting on:
- NASH Disease Incidence and Prevalence
- NAFLD Incidence and Prevalence
- Risk Factor Evaluation
- Pricing Trends
- Liver Transplant Statistics and Trends
- Expected Market Penetration
- Global Treatment Options and Emerging Therapies
NASH Drug Pipeline and Market Overview also covers the competitive outlook in the NASH treatment market, noting the activities of the current major players, which include:
- Intercept
- Genfit
- Allergan
- Madrigal
- Immuron
- Galectin
- Gilead
Related products
At-Home Diagnostic Testing Markets and Trends, 2023
June 6, 2023
Kalorama Information’s report, At-Home Diagnostic Testing Markets and Trends (COVID-19, FOB, Glucose, HIV, and Other Tests), 2023, delves into the expanding world of at-home and home collection tests. The at-home in vitro diagnostic (IVD) testing market comprises tests that can be purchased over the counter or online, where patients collect specimens and receive results within…
Price range: $4,000.00 through $6,000.00
The World Market for Veterinary Diagnostics, 7th Edition
January 22, 2024
Unlock the potential of the veterinary diagnostics market with Kalorama Information’s comprehensive report, The World Market for Veterinary Diagnostics, 7th Edition, which dives deep into the world of animal healthcare diagnostics. From disease identification to monitoring, veterinarians rely on a variety of tests for accurate diagnoses and effective treatment plans. Our report provides a detailed…
Price range: $5,000.00 through $7,875.00
In Vitro Diagnostics Business Outlook, 2024
December 20, 2024
In Vitro Diagnostics Business Outlook, 2024 is a must-have publication offering exclusive information and data that cannot be found elsewhere. With a focus on the in vitro diagnostics (IVD) market, this publication provides valuable insights to help businesses identify growth opportunities, understand market trends, and tailor strategies for success.
Key Features:
…
Price range: $1,976.50 through $5,025.00
